363 related articles for article (PubMed ID: 31030806)
1. Beta Thalassemia: Monitoring and New Treatment Approaches.
Khandros E; Kwiatkowski JL
Hematol Oncol Clin North Am; 2019 Jun; 33(3):339-353. PubMed ID: 31030806
[TBL] [Abstract][Full Text] [Related]
2. New therapeutic targets in transfusion-dependent and -independent thalassemia.
Cappellini MD; Motta I
Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):278-283. PubMed ID: 29222267
[TBL] [Abstract][Full Text] [Related]
3. Beta Thalassemia: New Therapeutic Options Beyond Transfusion and Iron Chelation.
Motta I; Bou-Fakhredin R; Taher AT; Cappellini MD
Drugs; 2020 Jul; 80(11):1053-1063. PubMed ID: 32557398
[TBL] [Abstract][Full Text] [Related]
4. Αlpha-thalassemia: A practical overview.
Musallam KM; Cappellini MD; Coates TD; Kuo KHM; Al-Samkari H; Sheth S; Viprakasit V; Taher AT
Blood Rev; 2024 Mar; 64():101165. PubMed ID: 38182489
[TBL] [Abstract][Full Text] [Related]
5. Recent Progress in Gene Therapy and Other Targeted Therapeutic Approaches for Beta Thalassemia.
Hamed EM; Meabed MH; Aly UF; Hussein RRS
Curr Drug Targets; 2019; 20(16):1603-1623. PubMed ID: 31362654
[TBL] [Abstract][Full Text] [Related]
6. β-Thalassemia intermedia: a comprehensive overview and novel approaches.
Asadov C; Alimirzoeva Z; Mammadova T; Aliyeva G; Gafarova S; Mammadov J
Int J Hematol; 2018 Jul; 108(1):5-21. PubMed ID: 29380178
[TBL] [Abstract][Full Text] [Related]
7. Thalassemia.
Aydinok Y
Hematology; 2012 Apr; 17 Suppl 1():S28-31. PubMed ID: 22507773
[TBL] [Abstract][Full Text] [Related]
8. Transferrin receptor 2 is a potential novel therapeutic target for β-thalassemia: evidence from a murine model.
Artuso I; Lidonnici MR; Altamura S; Mandelli G; Pettinato M; Muckenthaler MU; Silvestri L; Ferrari G; Camaschella C; Nai A
Blood; 2018 Nov; 132(21):2286-2297. PubMed ID: 30209118
[TBL] [Abstract][Full Text] [Related]
9. Preclinical transfusion-dependent humanized mouse model of beta thalassemia major.
Huo Y; McConnell SC; Ryan TM
Blood; 2009 May; 113(19):4763-70. PubMed ID: 19258591
[TBL] [Abstract][Full Text] [Related]
10. Clinical Features of β-Thalassemia and Sickle Cell Disease.
McGann PT; Nero AC; Ware RE
Adv Exp Med Biol; 2017; 1013():1-26. PubMed ID: 29127675
[TBL] [Abstract][Full Text] [Related]
11. Emerging Therapies in β-Thalassemia.
Bou-Fakhredin R; Kuo KHM; Taher AT
Hematol Oncol Clin North Am; 2023 Apr; 37(2):449-462. PubMed ID: 36907614
[TBL] [Abstract][Full Text] [Related]
12. Cardiac complications in thalassemia throughout the lifespan: Victories and challenges.
Wood JC
Ann N Y Acad Sci; 2023 Dec; 1530(1):64-73. PubMed ID: 37902424
[TBL] [Abstract][Full Text] [Related]
13. New strategies in the treatment of the thalassemias.
Schrier SL; Angelucci E
Annu Rev Med; 2005; 56():157-71. PubMed ID: 15660507
[TBL] [Abstract][Full Text] [Related]
14. Unmet needs in β-thalassemia and the evolving treatment landscape.
Njeim R; Naouss B; Bou-Fakhredin R; Haddad A; Taher A
Transfus Clin Biol; 2024 Feb; 31(1):48-55. PubMed ID: 38128605
[TBL] [Abstract][Full Text] [Related]
15. Alpha and beta thalassemia.
Muncie HL; Campbell J
Am Fam Physician; 2009 Aug; 80(4):339-44. PubMed ID: 19678601
[TBL] [Abstract][Full Text] [Related]
16. Alpha- and Beta-thalassemia: Rapid Evidence Review.
Baird DC; Batten SH; Sparks SK
Am Fam Physician; 2022 Mar; 105(3):272-280. PubMed ID: 35289581
[TBL] [Abstract][Full Text] [Related]
17. [Current management of thalassemia intermedia].
Thuret I
Transfus Clin Biol; 2014 Nov; 21(4-5):143-9. PubMed ID: 25282488
[TBL] [Abstract][Full Text] [Related]
18. Transfusion suppresses erythropoiesis and increases hepcidin in adult patients with β-thalassemia major: a longitudinal study.
Pasricha SR; Frazer DM; Bowden DK; Anderson GJ
Blood; 2013 Jul; 122(1):124-33. PubMed ID: 23656728
[TBL] [Abstract][Full Text] [Related]
19. 2021 update on clinical trials in β-thalassemia.
Musallam KM; Bou-Fakhredin R; Cappellini MD; Taher AT
Am J Hematol; 2021 Nov; 96(11):1518-1531. PubMed ID: 34347889
[TBL] [Abstract][Full Text] [Related]
20. Towards more successful gene therapy clinical trials for β-thalassemia.
Drakopoulou E; Papanikolaou E; Georgomanoli M; Anagnou NP
Curr Mol Med; 2013 Sep; 13(8):1314-30. PubMed ID: 23865429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]